Among the vaccines developed by Vietnamese companies, NanoCovax is considered the one that can ‘go far’, though the end point is unclear.

Vietnam strives to have at least one successful domestically developed COVID-19 vaccine this year, according to deputy health minister Tran Van Thuan.

Samples of Covivac, a Vietnamese produced coronavirus vaccine, have been sent to Canada for evaluation of its effectiveness, according to Prof. Dr. Dang Duc Anh, director of the National Institute of Hygiene and Epidemiology (NIHE).

The Khanh Hoa-based Institute of Vaccines and Medical Biologicals under the Ministry of Health in coordination with PATH organisation has jointly studied a COVID-19 vaccine called Covicac, which uses egg-based vaccine production technology.

Vietnam will continue to test the domestically-made Covid-19 vaccine called Covivac on 30 volunteers on March 23-25.

The clinical trial of the domestically-made Nanocovax vaccine is going smoothly, and by the end of September, Vietnam will have its first Covid-19 vaccine.

Vietnam is confident that it will be able to produce Covid-19 vaccines to meet the country’s need and for export by 2022.

The Hanoi Medical University is to start the initial phase of clinical trials on the second domestically-produced COVID-19 vaccine known as Covivac, developed by the Institute of Vaccines and Medical Biologicals (IVAC) on March 15.

A ceremony was held at the Hanoi Medical University on January 21 to kick-start clinical trials of COVIVAC, Vietnam’s second COVID-19 vaccine candidate and developed based on the new highly-infectious coronavirus variants.